The trajectory of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical landscape . Although its initial success and generation of vast in earnings , the intellectual property lapse has opened the way for competing medications, substantially diminishing profit prospects . This shift rai